Time to Progression of AFP (TPA) as a Predictor of Survival in Hepatocellular Carcinoma Treated with Sorafenib (SOR)

dc.contributor.authorGarrido Salvo, Marcelo
dc.date.accessioned2020-10-09T01:24:31Z
dc.date.available2020-10-09T01:24:31Z
dc.date.issued2014
dc.format.extent12 páginas
dc.fuente.origenConveris
dc.identifier.doi10.4236/jct.2014.514133
dc.identifier.issn2151-1934
dc.identifier.issn2151-1942
dc.identifier.urihttps://doi.org/10.4236/jct.2014.514133
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/47197
dc.issue.numeroNo. 14
dc.language.isoen
dc.nota.accesoContenido completo
dc.pagina.final1343
dc.pagina.inicio1332
dc.revistaJournal of Cancer Therapyes_ES
dc.rightsacceso abierto
dc.titleTime to Progression of AFP (TPA) as a Predictor of Survival in Hepatocellular Carcinoma Treated with Sorafenib (SOR)es_ES
dc.typeartículo
dc.volumenVol. 5
sipa.codpersvinculados7260
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Time to Progression of AFP (TPA).pdf
Size:
2.78 MB
Format:
Adobe Portable Document Format
Description: